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Group 2 innate lymphoid cells (ILC2s) represent a subset of
newly discovered immune cells that are involved in immune
reactions against microbial pathogens, host allergic reactions,
as well as tissue repair. The basic helix-loop-helix transcription
factors collectively called E proteins powerfully suppress the dif-
ferentiation of ILC2s frombonemarrow and thymic progenitors
while promoting the development of B and T lymphocytes. How
E proteins exert the suppression is not well understood. Here
we investigated the underlying molecular mechanisms using in-
ducible gain and loss of function approaches in ILC2s and their
precursors, respectively. Cross-examination of RNA-seq and
ATAC sequencing data obtained at different time points reveals
a set of genes that are likely direct targets of E proteins. Conse-
quently, a widespread down-regulation of chromatin accessibil-
ity occurs at a later time point, possibly due to the activation of
transcriptional repressor genes such as Cbfa2t3 and Jdp2. The
large number of genes repressed by gain of E protein function
leads to the down-regulation of a transcriptional network im-
portant for ILC2 differentiation.
Group 2 innate lymphoid cells (ILC2s) are a subset of innate
lymphoid cells (ILCs) that play important roles in initiating
type 2 immunity (1). They are enriched in barrier locations
such as the lung, intestine, and skin (2). They respond to signals
released by tissue damages, namely IL-25, IL-33 and TSLP, and
produce type 2 cytokines primarily consisting of IL-5, IL-9, and
IL-13 (3). However, ILC2s exist as heterogeneous popula-
tions with diverse characteristics and functionality due to
the influences of the tissues in which they reside and the cell
origins from which they arise (4, 5). A complete knowledge
of the ontogeny of ILC2s will help understand ILC2-medi-
ated immunity.
ILC2s are generated during fetal, neonatal, and adult stages,
among which the neonatal phase contributes to the majority of
the tissue-resident ILC2s (2). ILC2s differentiate from progeni-
tors such as common lymphoid progenitors (CLP) or lymph-
oid-multipotent progenitors, which are also responsible for
making B and T lymphoid cells as well as NK cells (6). ILC2 dif-
ferentiation has been thought to take place in the fetal liver and
bone marrow (3). However, we have established that this also
occurs in the thymus, where ILC2s not only differentiate from
multipotent early T cell progenitors, namely ETP or DN1
(CD42CD82CD252c-kit1) cells, but also from committed T
cell precursors, namely CD4-CD8-CD251c-kit2 (DN3) cells (5,
7, 8). In fact, the thymus is a fertile niche for ILC2 differentia-
tion when a critical checkpoint that ensures proper T cell devel-
opment is disabled.
The basic helix-loop-helix family of transcription factors,
collectively called E proteins, serve as a critical checkpoint to
promote B and T cell development and suppress ILC2 differen-
tiation (5, 7–10). In the thymus, the Tcf3 and Tcf12 genes are
expressed to produce their respective E proteins, E12 and E47
from Tcf3 and HEB from Tcf12. These proteins dimerize
among themselves and activate transcription by binding to the
DNA sequences called E boxes. When both genes are deleted
using a thymus-specifically expressed Cre, plck-Cre, T cell de-
velopment is blocked at the DN3 stage when the Cre transgene
is first expressed (7, 11). Consequently, an abundance of ILC2s
are generated in Tcf3 and Tcf12 double knock-out mice (dKO).
E protein function can be abolished by their naturally occurring
inhibitors, Id proteins, which dimerize with E proteins and pre-
vent DNA binding. When Id1 is ectopically expressed in the
thymus, T cell development is arrested and ILC2 development
is drastically enhanced, leading to accumulation of 10-100–fold
more ILC2s in different tissues (7). The promotion of ILC2 dif-
ferentiation in the absence of E protein activities are not simply
the result of T cell developmental blockade because numerous
other animal models with T cell defects (e.g. Rag12/2 mice) do
not exhibit such robust enhancement of ILC2 production.4
Thus, it is likely that E proteins play a specific role in suppress-
ing ILC2 differentiation.
To understand the underlying mechanisms, we sought to
elucidate the transcriptional programs controlled by E proteins
in the context of ILC2 differentiation. We measured transcrip-
tomes and chromatin accessibilities in T cell precursors and in
ILC2s upon inducible loss or gain of E protein function. We
observed dynamic changes in gene regulation, which ultimately
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leads to a suppression of ILC2 transcriptional programs by E
proteins.
Results
Altered gene expression immediately following inducible E
protein ablation in T cell precursors
In addition to our previous report of the substantial increase
in ILC2 numbers in Tcf3 and Tcf12 double knockout mice, we
have also shown that deletion of these genes using tamoxifen-
inducible Cre enhances ILC2 differentiation from CLP, DN1,
and DN3 cells by 20-40–fold when cultured on OP9-DL1 stro-
mal cells for 11-14 days (5, 7). To detect changes in gene
expression immediately following E protein ablation, we iso-
lated sufficient DN1 and DN3 cells for RNA-seq after brief cul-
tures on OP9-DL1 stromal cells. We seeded stromal cells with
DN1 or DN3 cells isolated from ROSA26-CreERT2;ROSA26-
Stop-tdTomato;Tcf3f/f;Tcf12f/f (dKO) mice or control mice that
were without the floxed alleles of the E protein genes. 4 days
later, tamoxifen was added and tdTomato1 (indicative of suc-
cessful Cre-mediated deletion) cells were sorted 24 and 72 h
later for RNA-seq (Fig. 1a). At these time points, few ILC2s
were detected (5), thus allowing the evaluation of early changes
in gene expression in ILC2 precursors.
The transcriptomes of dKO cells and controls at 24 and 72 h
were compared separately (Fig. 1b). Although there were sub-
stantial overlaps between the differential genes at 24 and 72 h
in DN1 and DN3 cells, differences were also found in terms of
the magnitude of changes and genes differentially expressed.
DN3 cells harbor a higher level of endogenous E proteins than
DN1 cells, mostly due to the up-regulation of Tcf12 (RRID:
SCR_019014), and thus the peak time of the changes for some
of the genes were delayed compared with DN1 cells. Overall,
we obtained lists of 1140 and 1376 differentially regulated pro-
tein coding genes at either time point in DN1 and DN3 cells,
respectively (Table S1).
DN1 and DN3 cells, being at different developmental stages,
have distinct transcriptomes. Because E protein ablation pro-
moted ILC2 differentiation from both cell types, a common
set of differential genes will be extremely informative for
understanding how E proteins suppress ILC2 differentiation.
Remarkably, a profound number of genes up-regulated due to
E protein ablation are known to be associated with ILC differ-
entiation. For example, this list consists of Zbtb16, Rora, Maf,
Lmo4, Klf6, Icos, Itgb7, Ikzf2, Irf4, and Gata3 (Fig. 1c). Con-
versely, among the genes down-regulated by the loss of E pro-
teins are genes previously known to be activated by E proteins
and important for T cell development (Fig. 1d) (12). These
include Rag1, Rag2, Notch1, Notch3, Cd3g, Cd3d, Ptcra, and
Spib. These data indicate an instrumental role for E-protein
activity in controlling the switch between ILC2 and T cell
development.
Not all of the genes found in our analyses are directly regu-
lated by E proteins. To identify direct targets, we compared the
list of genes altered in DN3 cells to E2A-ChIP-seq data gener-
ated by Murre and colleagues (Fig. 1e) (12). Eighty-nine differ-
entially regulated protein-coding genes in cultured DN3 cells
were found to be bound by E2A proteins in Rag22/2 thymo-
cytes, which are mostly cells arrested at the DN3 stage, suggest-
ing that these genes are likely direct targets of E proteins.
Although the overlap between our RNA-seq results and the
ChIP-seq data are highly significant in a Fisher test, the small
number of genes overlapped in the two datasets may be due to
changes in gene expression that already occurred after a 4-day
culture of DN3 cells on OP9-DL1 stroma before E protein dele-
tion, such that their transcriptional profile is intrinsically differ-
ent from that of ex vivo Rag22/2 DN3 cells, which lack pre-
TCR signaling.
To further verify our results, we examined the protein levels
of several transcription factors whose transcripts were found to
be altered by E protein ablation and to which suitable antibod-
ies are available for flow cytometry (Fig. 1f). As we did for RNA-
seq, we cultured DN3 cells from ROSA26-CreERT2;ROSA26-
Stop-tdTomato;Tcf3f/f;Tcf12f/f (dKO) or mice expressing only
tdTomato on OP9-DL1 stromal cells for 4 days and then added
tamoxifen. 2 days later, cells were harvested and stained with
antibodies against CD45.2, TCRb, TCRgd, and ICOS along
with transcription factors, GATA3, HELIOS, IRF4, and TCF1.
At this time point, very few cells have differentiated into
ILC2, which would express ICOS, even though E protein-defi-
cient cells had more ICOS1 cells (Fig. 1f). These ICOS1 cells
were excluded in our analyses to ensure a fair comparison.
CD45.21TCRb-TCRgd-ICOS-tdTomato1 cells were examined
for levels of the transcription factors. Compared with tdTomato
only controls, GATA3 and HELIOS expression is markedly
increased in dKO cells, which is consistent with the elevation of
their transcripts (Fig. 1f). However, the IRF4 level changed little
even though its transcript was also augmented by E protein
ablation. Perhaps, a different kinetics applied to the synthesis is
the IRF4 protein. In contrast, the transcript for TCF1 (encoded
by Tcf7) was found to be down-regulated upon E protein dele-
tion, the protein level did not increase but showed a trend of
reduction (Fig. 1f). We have also measured the levels of these
proteins on day 3 post induction and similar results were
obtained (data not shown). Together, these results largely agree
with our transcriptome analyses.
Transcript levels altered by inducible E protein activity in
ILC2s
We next took a complementary approach by examining gene
expression in ILC2s after overexpression of an inducible E pro-
tein, E47-ER, in which E47 was fused to a modified hormone-
binding domain of estrogen receptor (13). E47 activity can then
be quickly induced by releasing the fusion protein from the
cytoplasm to the nucleus upon binding to tamoxifen. We made
use of our Id1 transgenic mice, in which a large amount of
functional ILC2s are produced in the thymus (7). Thymic
ILC2s were harvested from these mice by sorting for Lin2
Thy11ICOS1ST21 cells and stimulated to proliferate with IL2,
IL7, IL25, and IL33. These cells were then transduced with ret-
roviruses expressing E47-ER and EGFP or EGFP alone at a rela-
tively high efficiency (about 30%). Transduced cells were sorted
for EGFP expression and expanded before treatments with ta-
moxifen for 4 and 16 h, respectively, and RNA-seq was per-
formed (Fig. 2a). These short time points were chosen to detect
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immediate effects of E47 and to avoid any toxicity of E47 known
to exist in B and T cells. Interestingly, ILC2s appeared to have
tolerated E47 remarkably well within 16 h (data not shown).
At 4 and 16 h post induction, 436 and 596 genes were found
to be differentially regulated, respectively (Fig. 2b, Table S2). In
both cases, many more genes were found to be up-regulated by
E47 than down-regulated. The differential genes can be divided
into two sets: time-independent and time-dependent (Fig. 2c).
The former includes genes whose expression changed statisti-
cally similarly at 24 and 72 h, which may be indicative of direct
effects of E47. The latter consist of genes that exhibit slower
kinetics in their activation or are indirectly affected by E47.
To narrow down the list of genes controlled by E proteins,
we compared genes altered by loss of E proteins in either DN1
or DN3 cells (Fig. 1) to those affected by E47 overexpression in
ILC2s, aiming to find genes altered in opposite directions.
Genes that passed the threshold of combined log2-fold change
(LFC). 1 and false discovery rate (FDR), 0.05 were obtained
(Fig. 2d, Table S3). Between the DN1 and DN3 sets, we found
80 protein-coding genes in common, which might be more rel-
evant to the suppression of ILC2 differentiation (Fig. 2e). It is
noted that the majority of the genes in this group are known to
be direct targets of E proteins such as Tcf12, Cdk20, Gfi1, and
Ets1 (Fig. 1e). We reasoned that shortage of down-regulated
genes found in this assay was because the 16-h window is too nar-
row to detect decreases inmRNA levels, which heavily depend on
the repression of transcription by newly made repressors and
turnover of existing transcripts.
Dynamic changes in chromatin accessibility upon inducible
E47 expression
To better understand how E proteins inhibit ILC2 differen-
tiation or function, we need to further examine the genes
directly or indirectly down-regulated by overexpression of E47
in ILC2s. We thus determined the chromatin accessibility in
ILC2s using the technique called Assay for Transposase-Acces-
sible Chromatin using sequencing (ATAC-seq) (14). We used
retroviral transduced cells carrying E47-ER or a control vector
treated as described in Fig. 2a for ATAC-seq.
Using a threshold of over 2-fold change with a FDR , 0.01,
we found about 1300 peaks increased by E47 at 4 h but less than
100 peaks decreased (Fig. 3b; Table S4). However, by 16 h, 815
peaks were elevated by E47 but 4735 peaks were reduced, which
suggest major changes in chromatin accessibility, resulting in
transcriptional repression (Fig. 3b, Table S4). These changes
correspond to less than 2% of all peaks detected, suggesting
that the assays were specific to E47 activity rather than nonspe-
cific effects. Approximately 80% of differential peaks are associ-
ated with protein coding genes. Regarding genomic distribu-
tion, most peaks reside in the intronic and intergenic regions
(Fig. 3c), consistent with the primary roles of E proteins and
other transcription factors in regulating transcription through
enhancers or super-enhancers.
The differential peaks obtained between E47-ER and control
cells were then assigned to the nearest annotated gene. The
numbers of up-regulated genes are 973 and 666 at 4 and 16 h
post tamoxifen addition, respectively. Among them, 483 genes
are common at both time points. The smaller number of up-
regulated genes at 16 hmight be attributed to negative feedback
mechanisms. In contrast, the numbers of down-regulated genes
were drastically different: 82 versus 2635 at 4 and 16 h, respec-
tively. Most of the genes found to be repressed at 4 h remained
down-regulated at 16 h. Because E47 is best known as a tran-
scriptional activator, the profound increase in genes inhibited
by E47 induction at 16 h suggests the induction of transcrip-
tional repressors by E proteins.
Analyses of transcription factor-binding sites within differ-
ential peaks reveals that at 4 h, E boxes recognized by basic he-
lix-loop-helix transcription factors such as E proteins were
most abundant, representing over 50% of the binding sites
found compared with a background of 18% in all open chroma-
tin regions (Fig. 3d). This suggests the direct involvement of
E47 in the increased chromatin accessibility observed (Fig. 3a).
Interestingly, by 16 h, the predominant binding sites found in
the differential peaks have shifted to the sites bound by bZip
and GATA transcription factors. The known motif analysis
revealed binding sites for different subgroups of bZip proteins
including ATF3, BATF, JUN, FOS, BACH2, and MAF (Fig. S1).
The large increase in the number of down-regulated regions
(;4,735 peaks) may result from the secondary effects of
the gene products initially elevated by E47 induction. These
repressed motifs predominated over the E boxes directly asso-
ciated with E47 binding. Indeed, when only elevated peaks were
analyzed for their binding sites, E boxes remained the most
prevalent (data not shown). Together, these analyses illustrated
a dynamic change in chromatin accessibility within the 16 h af-
ter induction of E47 activity.
Genes initially activated by E47 may lead to repression of
ILC2 genes later
We next correlated the ATAC-seq data with the RNA-seq
results in EGFP or E47-ER/EGFP retrovirus-transduced ILC2s
Figure 1. Transcriptome changes immediately after E protein ablation. a, experimental design. DN1 and DN3 thymocytes from ROSA26-CreERT2;
ROSA26-stop-tdTomato;E2Af/f;HEBf/f (dKO) and ROSA26-CreERT2;ROSA26-stop-tdTomato (control) mice were co-cultured on OP9-DL1 stromal cells. Biological
duplicates were collected 24 and 72 h later and sorted for tdTomato expression before RNA isolation and sequencing. b, numbers of differentially expressed
genes comparing dKO and control at the indicated time points and cell preparations. Genes with a log2-fold change. 1 and FDR, 0.05 were counted. c and
d, Venn diagrams show the overlaps of genes up and down-regulated in DN1 and DN3-derived cells. Expression levels of genes commonly found in both DN1
and DN3-derived cells are shown in heat maps below each Venn diagram with representative genes listed. e, Venn diagram compares protein-coding genes
differentially expressed in DN3-derived cells to genes assigned to anti-E protein (E47) ChIP-seq peaks detected in ex vivo Rag22/2 thymocytes. Fisher test was
used to determine the statistical significance of the overlap (p, 0.00001). Heatmap shows the relative levels of expression in DN3-derived cells with represen-
tatives listed on the side. f, intracellular staining of transcription factors in DN3 cells from ROSA26-CreERT2;ROSA26-stop-tdTomato;E2Af/f;HEBf/f (dKO) and
plck-Cre;ROSA26-stop-tdTomato (control) mice were cultured as described in a. 2 days later, the cells were stained with antibodies against surface markers
and the indicated transcription factors. Gating strategies are as illustrated. Data shown are representatives of cultures set up independently with two mice of
each strain. Similar results were also obtained on day 3 after induction.
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after the same treatments with tamoxifen. We looked for genes
whose expression patterns changed in the same manner upon
E47 induction. The thresholds of ATAC-seq data were set at a
LFC. 1 and FDR, 0.01. Because we reasoned that changes in
mRNA levels, particularly the reduction of transcripts, may be
slower than alterations in chromatin accessibility, the threshold
for the RNA-seq data were set at FDR, 0.05 without the LFC
cutoff to maximize the detection of any trend of gene expres-
sion change (Fig. 4a). Four hours after E47 induction, the ma-
jority of the common differential genes are up-regulated. In
contrast, by 16 h, the majority of genes were down-regulated.
Additionally, we observed a significant fraction of genes that
were increased as detected by RNA-seq but negatively regu-
lated by ATAC-seq, which may illustrate the enhanced sen-
sitivity of ATAC-seq in detection of dynamic gene repres-
sion at 16 h. The delayed appearance of down-regulated
Figure 2. Transcriptome changes upon inducible expression of E47-ER. a, experimental scheme. b, numbers of differentially expressed genes comparing
E47-ER/EGFP to EGFP-transduced cells at 4 and 16 h. Genes with LFC. 0.5 and FDR, 0.05 were counted. c, expression levels of genes altered similarly (time-
independent) and differently (time-dependent) at 4 and 16 h are separately shown in heat maps with genes of interest listed. d, gene expression changed in
opposite direction in E protein-deficient and E47-ER expressing cells are plotted (FDR, 0.05). e, Venn diagram shows the number of shared protein-coding
genes in d between DN1 andDN3-derived cells. Relative levels of the 80 common genes are displayed in the heat mapwith representatives listed.
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genes supports our hypothesis that E47 indirectly causes
gene repression.
We then set out to identify putative candidates that may
mediate the profound chromatin remodeling observed at 16 h.
Fig. 4b shows a list of more dramatically up-regulated genes at
both 4 and 16 h. Among them, several transcriptional repress-
ors stood out. The signal tracks of a few select genes are
displayed in Fig. 4c. For example, expression of Cbfa2t3,
which encodes MTG16 (also called ETO2), was significantly
enhanced at 4 h and continued to increase by 16 h. The differ-
ential peaks were detected ;1, 3, and 13 kb upstream of the
transcription start site. These peaks overlap with the region
observed in ChIP against methylated K4 of histone 3 (H3K4me)
in thymocytes (available at ENCODE, RRID:SCR_015482), sug-
gesting that these regions may contain enhancers. MTG16 is a
known transcriptional repressor capable of recruiting histone
deacetylases (15, 16). Interestingly, Cbfa2t3 has been shown to
be expressed at very low levels in ILC2Ps compared with their
precursors in the bone marrow (Fig. S2) (17), suggesting that
down-regulating this gene is necessary for ILC2 differentiation.
ILC2s in small intestine also express Cbfa2t3 at a low level. Fur-
thermore, we found that 127 genes up-regulated in Cbf2at32/2
hematopoietic stem cells (LSK) (18) overlap with the genes
assigned to diminished peaks at 16 h in ILC2s (p , 2.2e-16)
(Fig. 4d). Considering the difference of the cell types in which
the two sets of data were generated, the overlap is remarkable
and supports the repressive role ofCbfa2t3 products in ILC2s.
However, there are likely to be other repressors that mediate
the suppressive function of E proteins in addition to MTG16.
Jdp2 is a transcriptional repressor dimerizing with the Jun fam-
ily of leucine-zipper transcription factors (19), many of which
are expressed in ILC2s. Jdp2 can recruit histone deacetylase 3,
thus regulating histone modification and chromatin assembly
(20, 21). This is particularly relevant in our study because we
observed widespread decreases in ATAC peaks at 16 h, and
these peaks are predominantly populated with bZip transcrip-
tion factor binding sites (Fig. 3d, Fig. S1). Thus, Jdp2 is a proba-
ble candidate for mediating gene repression at 16 h. Another
Figure 3. ATAC-seq analyses in E47-ER expressing cells. a, cells used in ATAC-seq analyses were treated as described in the legend to Fig. 2a. Numbers of
peaks whose levels were increased or decreased compared with E47-ER expressing and control cells at 4 and 16 h are as indicated. The cutoffs for peak calling
are LFC. 1 and FDR, 0.01. b, distribution of differential peaks across the genome at each time point. c, numbers of genes assigned to the peaks and those
that overlap between the two time points. d, tables showing the top 5 most enriched transcription factor-binding motifs in differentially accessible peaks at 4
and 16 h. Binding sites that best match the transcription factor families are shown in the right column. NR stands for nuclear receptors.
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up-regulated bZip transcription repressor is Bach2 (22). Its
binding sites are readily detectable in ATAC peaks at 16 h (Fig.
S1). Considering the inhibition of Th2 differentiation by Bach2
(23, 24), it could also contribute to the suppression of the ILC2
fate.
Finally, several genes encoding proteins related to the Wnt
signaling pathway, Wnt10b, Wisp, and Snai, are on top of
the list of up-regulated genes shown in Fig. 4b. Given the
crucial roles of Wnt signaling in regulating various develop-
mental programs (25, 26), it may play an important role in
ILC2 suppression.
Down-regulation of a network of transcriptional programs
for ILC2 differentiation by E47
The large amount of ATAC peaks found to be reduced by
E47 at 16 h may provide plausible hints as to how E proteins
suppress ILC2 differentiation. We thus performed pathway
analysis on the genes regulated in similar manners at 16 h as
detected using RNA-seq and ATAC-seq (Fig. 4a). Consistent
with our expectations, the top canonical pathway found to be
down-regulated by E47 is related to T helper 2 cells. The top-
ranking network of transcriptional programs includes key tran-
scription factors and signaling molecules known to be ILC
Figure 4. Initial transcriptional activation followed up widespread gene repression. a, correlation of mRNA levels and chromatin accessibility. LFC of
ATAC peaks andmRNA levels in E47-ER expressing cells at each time point are plotted on x and y axis, respectively. b, top up-regulated genes at 4 and 16 h are
plotted. c, ATAC peak tracks at the indicated time points and cells are shown for representative genes as indicated. H3K4me ChIP-seq data were generated
using thymocytes by the ENCODE consortium. d, comparison of genes repressed byMTG16 (encoded by Cbfa2t3) in hematopoietic stem cells (LSK) and genes
repressed in E47-ER expressing ILC2s at 16 h. Fisher test shows the statistical significance of the overlap (p , 0.00001). A select list of the genes are shown
below the Venn diagram.
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signatures such as IL-7R, TOX, IRF4, MAF, KLF6, and RBPJ
(Fig. 5a) (4, 5, 17, 27). The reduction in chromatin accessibility
of the key ILC2 signature genes is striking. For example, 15
peaks assigned to Maf were found to be diminished by at least
2-fold (Fig. S3). Likewise, 3 peaks each were reduced for Tox
and Irf4, respectively.
Id2 and Id3 were up-regulated by E47 in the treated cells
because these genes are known to be activated by E proteins in
a feedback loop that helps maintain the net activity of E pro-
teins (28). Because E47-ER overexpressed in the cells would
likely outcompete endogenous Id proteins, the small increases
in Id2 and Id3 mRNA levels may not be consequential. How-
ever, the major nodes formed around Id2 and Id3 highlight the
importance of the helix-loop-helix family of transcription fac-
tors such as E47 in regulating ILC2 differentiation and their
interplay with other transcription factors (Fig. 5a).
To correlate the ATAC-seq data with gene expression
changes caused by E protein ablation in both DN1- and DN3-
Figure 5. Loss and gain of E protein function impact a similar transcription program regulating ILC2 differentiation. a, ingenuity pathway analysis of
differential peaks detected at 16 h after E47-ER induction. The top transcription network (score = 45) is shown. Up- and down-regulated genes are depicted in
red and green. Multiple peaks assigned to the same gene are indicated with an asterisk. Arrows show connections between two genes, mostly by positive or
negative influence in expression. b, inverse correlation between the effects of loss and gain of E protein function. LFC of differentially expressed genes in both
DN1- and DN3-derived cells is plotted against the changes in E47 expressing cells at 16 h. Genes increased and decreased in E protein-deficient cells are high-
lighted in red and green, respectively. c, top network identified using the ingenuity pathway analysis of inversely correlated genes as shown in b (score = 38). d,
summary of the expression profiles of key genes regulated by E proteins in relationship to ILC2 differentiation.
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initiated ILC2 cultures (Fig. 1), we plotted fold-changes in
mRNA levels and ATAC-seq peaks (Fig. 5b). We focused on
the inverse relationship between the two datasets. There are
206 and 72 genes up- and down-regulated upon E protein gene
deletion, which are assigned to peaks decreased and increased
in ATAC-seq, respectively. Ingenuity pathway analysis of these
commonly regulated genes revealed the top regulatory network
consisting of key regulatory proteins in ILC2 differentiation.
The same molecules found to be down-regulated by E47
expression in ILC2s, IRF4, MAF, and KLF6, are shown to be
up-regulated during ILC2 differentiation of E protein-deficient
DN1 and DN3 thymocytes (Fig. 5, a and c). Conversely, genes
activated by E47 are diminished with E protein ablation, which
include Id3, Jdp2, Jak2, Bcl2l11, and Btg2. In addition, several
more genes encoding transcription factors potentially impor-
tant for ILC2 differentiation, such as Gata3, Batf, Nfil3, Ahr,
Ikzf2, Prdm1, Fos, and Fosb were also deemed to be up-regu-
lated in E protein-deficient DN1 and DN3 cells and down-regu-
lated by E47 as detected by ATAC-seq.
Discussion
This study uses inducible loss and gain of E protein function
models to cross-examine transcription programs in the context
of ILC2 differentiating cells or ILC2s and the consensus is sum-
marized in Fig. 5d. By following changes in mRNA levels or
chromatin accessibility shortly after alterations in E protein ac-
tivity, we have a unique opportunity to postulate a cascade of
regulatory events that lead to E protein-mediated suppression
of ILC2 differentiation. Induction of E47 in ILC2s quickly led to
the up-regulation of repressor genes, which in turn cause coor-
dinated transcriptional repression of a network of transcrip-
tional programs important for the ILC2 cell fate. In particular,
Cbfa2t3, encoding MTG16 (or ETO2), is dramatically up-regu-
lated by E47 and it is also highly expressed in T cell precursors.
MTG16 not only interacts with E proteins but also forms super
complexes with GATA1, E proteins, Tal1, Lmo2, and Ldb in
erythroid cells (29, 30). MTG16 is also important for T cell de-
velopment, as well as the differentiation of plasmacytoid den-
dritic cells (31, 32). It is thus conceivable that E proteins recruit
MTG16 and cooperate with GATA3 and Lmo2/4 to suppress
the ILC2 fate in bonemarrow and T cell precursors where these
proteins all exist. Equally plausible is the action of negative reg-
ulators of a large class of basic leucine zipper transcription fac-
tors including products of Jdp2 and Bach2. The enrichment of
bZip transcription factor-binding sites in the ATAC peaks
decreased at the 16-h time point would argue for the impor-
tance of this class of transcription factors in controlling the
genes necessary for ILC2 identity and function. Therefore, it is
likely that the concerted efforts of multiple axes of positive
and negative regulation of transcription dictate the develop-
mental trajectory of progenitor cells of either innate or adapt-
ive lymphoid cells.
E proteins are known to promote B and T lymphoid cell com-
mitment, partly through their ability to facilitate the produc-
tion of proteins involved in antigen receptor signaling (33).
However, simply pushing the B and T cell-specific function
may not be sufficient and suppression of other cell fates, such
as the myeloid and innate lymphoid paths could also be neces-
sary (34, 35). Conversely, the differentiation into ILC2 or other
ILCs requires the inhibition of E protein function by their
inhibitors, the Id proteins. Id2 is well known to be essential of
ILC differentiation (36). Id3 is known to be transiently up-regu-
lated by pre-T cell receptor signaling (37). Therefore, Id2 and
Id3 may act by antagonizing the E protein activities we have
elucidated in this study to promote ILC differentiation from in
common lymphoid progenitors in the bone marrow or T cell
precursors in the thymus.
Experimental procedures
Mice and OP9 stromal culture
ROSA26-CreERT2;ROSA26-Stop-tdTomato;Tcf3f/f;Tcf12f/f
(dKO) mice and controls lacking to the floxed Tcf3 and Tcf12
are as described (5, 7). CLP from the bone marrow and DN1
or DN3 cells from the thymus were sorted and cultured as
described (5). Briefly, cells were seeded at 100 or 1000 cells/
well in 48-well–plates containing a layer of OP9-DL1 stromal
cells plated 24 h before. The culture medium contains 20%
bovine fetal calf serum, 30 ng/ml of each IL-2, IL-7, and stem
cell factor (all from R&D systems) in a-minimal essential me-
dium (Gibco, ThermoFisher). On day 4, 4-hydroxy-tamoxifen
was added to a concentration of 1 mM. Cells were harvested
24 and 72 h later and CD451tdTomato1 were sorted and
used for RNA-seq. For intracellular staining of transcription
factors, cells were analyzed 48 h after addition of tamoxifen.
Retroviral transduction in ILC2s
To purify ILC2s from the thymus of plck-Id1tg/tg mice, thy-
mocytes were stained with anti-CD90.2 (53-2.1), anti-ST2
(DIH9), anti-ICOS (C398.4A), and a mixture of lineage (Lin)-
specific antibodies: anti-FceR (MAR-1), anti-B220 (RA3-6B2),
anti-CD19 (ID3), anti-Mac-1 (M1/70), anti-Gr-1 (R86-8C5),
anti-CD11c (N418), anti-NK1.1 (PK136), anti-Ter-119 (Ter-
119), anti-CD3e (145-2C11), anti-CD5 (53-7.3), anti-CD8a
(53-6.7), anti-TCRb (H57-597), and anti-gdTCR (GL-3; eBio-
science). All antibodies are from Biolegend unless specified
otherwise. Lin-CD90.21ICOS1ST21 cells were sorted on a
FACSAria II (BD Biosciences). The cells were plated on 96-well
U-bottom plates at 80,000 cells/well in a-minimal essential me-
dium containing 10% fetal calf serum, 10 ng/ml each IL-2, IL-7,
IL-25, and IL-33. Cells were split 1:3 on day 3 and placed onto
96-well flat-bottom plates and spin-infected with retrovirus the
next day. Spin-infection was performed by mixing retroviral
stocks and cultured cells at a 1:1 ratio plus the addition of 8 mg/
ml of Polybrene. The retroviral stocks are as described (13).
The cells were centrifuged for 1.5 h at 1,300 rpm before the
plates were returned to the 37 °C incubator with 5% CO2. After
6 h, the culture was replaced with fresh medium and incubated
for 2 days. Transduced cells were sorted for the expression of
EGFP and cultured for 3 additional days in U-bottom plates
with the same medium. These cells with or without E47-ER
were induced with 1 mM 4-hydroxy-tamoxifen for 4 or 16 h and
harvested.
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RNA and ATAC sequencing
RNA was isolated using the TRIzol reagent per the vender’s
instructions (Life Technology). RNA-seq was performed in
duplicate by the Clinical Genomics Center at the Oklahoma
Medical Research Foundation using the Ovation RNA-Seq Sys-
tem (NuGEN Technologies Inc., San Carlos, CA) followed by
KAPA Hyper library preparation kits (KAPA Biosystems, Wil-
mington, MA) on an Illumina NextSeq 500 sequencing plat-
formwith 76-bp paired-end reads (Illumina, San Diego, CA).
ATAC-seq was also performed in duplicate for each time
point and cell type. ATAC transpose reactions were carried
out using the NX#-TDE1, TAGMENT DNA enzyme, and
buffer from Illumina. The reaction was purified using Qiagen
miniElute columns, which is followed by PCR amplification
with matching primers. The PCR products were purified using
magnetic beads and eluted in EB buffer (Qiagen). The products
were sequenced using an Illumina NextSeq 500 sequencing
platformwith 76-bp paired-end reads.
Analyses of RNA-seq data
Raw sequencing reads (in a FASTQ format) were trimmed
using Trimmomatic to remove any low-quality bases at the be-
ginning or the end of sequencing reads as well as any adapter
sequences. Trimmed sequencing reads were aligned to theMus
musculus genome reference (GRCm38/mm10) using STAR
version 2.4.0h (38). Gene-level read counts were determined
using HTSeq version 0.5.3p9 (39) with the GENCODE Release
M10 (GRCm38) annotation. Only autosomal genes coding for
lncRNAs, miRNAs, and protein-coding mRNAs were selected
for analyses.
Read-count normalization and differentially expressed analy-
ses was performed using the edgeR package from Bioconduc-
tor. Expression values normalized with the voom function were
analyzed for differential expression using the standard func-
tions of the limma program. Each transcript expression varia-
tion was tested with the moderated t-statistics and the corre-
sponding p values were adjusted formultiple testing using FDR.
Unless specified, sets of differentially expressed transcripts
were filtered requiring at least 2-fold change in expression and
a FDR below 0.05. Overrepresented functional gene sets
(GO, KEGG pathways) were identified using specialized R
Bioconductor packages. Ingenuity Pathway Analysis (Qia-
gen) was used to explore significant gene networks and
pathways interactively.
ATAC data processing and analysis
Alignment and peak-calling of ATAC sequencing data were
performed using the ENCODE-DCC ATAC-Seq pipeline
(https://github.com/ENCODE-DCC/atac-seq-pipeline (40).
Briefly, data were aligned to mm10 genome using Bowtie2
(41). Aligned data were filtered for PCR duplicates, black-
listed regions, and shifted 14 bp for the plus (1) strand and
25 bp for the minus (–) strand. Peaks were called using
MACS2 (42) and filtered by irreproducible discovery rate
(IDR , 0.1) (https://github.com/nboley/idr). Differential
peak calling was performed using differential binding analy-
sis of ChIP-seq peak data (DiffBind, http://bioconductor.org/
packages/release/bioc/vignettes/DiffBind/inst/doc/DiffBind.pdf)
(43), where a consensus peak set of 60,543 peaks was derived
from all samples, and a window of 150 bp was centered on peak
summits for further downstream analysis. DESeq2 (44) was used
to perform differential peak analysis with DE peaks identified by
q , 0.05 and absolute log fold-change . 1. Motif enrichment
was performed using Hypergeometric Optimization of Motif
EnRichment program (HOMER) version 4.1 (45), where the
backgroundwas set as the union of all ATACpeaks.
Data availability
Raw data for RNA-seq and ATAC-seq can found in the GEO
database GSE111518 for E protein-deficient cells on OP9-DL1
culture; GSE151739 for E47-ER transduced ILC2s. Other data
are presented in themanuscript including supportingmaterial.
Acknowledgments—We are grateful to Dr. GrahamWiley for advice
in the ATAC-seq experiments and the Clinical Genomics Center
and Flow Cytometry Facility at the Oklahoma Medical Research
Foundation for outstanding technical assistance. We thank Dr.
Marco Colonna for advice and support.
Author contributions—V. P. and C. G. carried out bioinformatics
analyses; A. B., A. P., L. Q., and X.-H. S. generated the data; V. P.,
C. G., J. D. W. and X.-H. S. analyzed the data and wrote the
manuscript.
Funding and additional information—This work was supported by
National Institutes of Health Grant 1R01AI126851 and the Presby-
terian Health Foundation (to X.-H.S), and National Institutes of
Health Grants 1P20 GM103636-07 (to J. D. W. and X.-H. S.) and
T32DK077653-28 (to V. P.). X.-H.S holds the Lew and Mira Ward
Chair in Biomedical Research at the Oklahoma Medical Research
Foundation. The content is solely the responsibility of the authors
and does not necessarily represent the official views of the National
Institutes of Health.
Conflict of interest—The authors declare that they have no conflicts
of interest with the contents of this article.
Abbreviations—The abbreviations used are: ILC2s, group 2 innate
lymphoid cells; CLP, common lymphoid progenitor; dKO, double
knockout; LFC, log2-fold change; FDR, false discovery rate; ATAC,
assay for transposase-accessible chromatin using sequencing; IL,
interleukin; EGFP, epidermal growth factor protein.
References
1. Vivier, E., Artis, D., Colonna, M., Diefenbach, A., Di Santo, J. P., Eberl, G.,
Koyasu, S., Locksley, R. M., McKenzie, A. N. J., Mebius, R. E., Powrie, F.,
and Spits, H. (2018) Innate lymphoid cells: 10 years on. Cell 174, 1054–
1066 CrossRefMedline
2. Schneider, C., Lee, J., Koga, S., Ricardo-Gonzalez, R. R., Nussbaum, J. C.,
Smith, L. K., Villeda, S. A., Liang, H. E., and Locksley, R. M. (2019) Tissue-
resident group 2 innate lymphoid cells differentiate by layered ontogeny
and in situ perinatal priming. Immunity 50, 1425–1438 CrossRefMedline
3. Artis, D., and Spits, H. (2015) The biology of innate lymphoid cells.Nature
517, 293–301 CrossRefMedline
Transcriptional regulation by E proteins in ILC2s














4. Ricardo-Gonzalez, R. R., Van Dyken, S. J., Schneider, C., Lee, J., Nussbaum,
J. C., Liang, H. E., Vaka, D., Eckalbar,W. L., Molofsky, A. B., Erle, D. J., and
Locksley, R. M. (2018) Tissue signals imprint ILC2 identity with anticipa-
tory function.Nat. Immunol. 19, 1093–1099 CrossRefMedline
5. Qian, L., Bajana, S., Georgescu, C., Peng, V., Wang, H. C., Adrianto, I.,
Colonna, M., Alberola-Ila, J., Wren, J. D., and Sun, X. H. (2019) Suppres-
sion of ILC2 differentiation from committed T cell precursors by E protein
transcription factors. J. Exp. Med. 216, 884–899 CrossRefMedline
6. Yang, Q., and Bhandoola, A. (2016) The development of adult innate
lymphoid cells.Curr. Opin. Immunol. 39, 114–120 CrossRefMedline
7. Wang, H. C., Qian, L., Zhao, Y., Mengarelli, J., Adrianto, I., Montgomery,
C. G., Urban, J. F., Jr., Fung, K. M., and Sun, X. H. (2017) Downregulation
of E protein activity augments an ILC2 differentiation program in the thy-
mus. J. Immunol. 198, 3149–3156 CrossRefMedline
8. Miyazaki, M., Miyazaki, K., Chen, K., Jin, Y., Turner, J., Moore, A. J., Saito,
R., Yoshida, K., Ogawa, S., Rodewald, H. R., Lin, Y. C., Kawamoto, H., and
Murre, C. (2017) The E-Id protein axis specifies adaptive lymphoid cell
identity and suppresses thymic innate Lymphoid cell development. Immu-
nity 46, 818–834 CrossRefMedline
9. Murre, C. (2005) Helix-loop-helix proteins and lymphocyte development.
Nat. Immunol. 6, 1079–1086 CrossRefMedline
10. Ling, F., Kang, B., and Sun, X. H. (2014) Id proteins: small molecules,
mighty regulators.Curr. Top. Dev. Biol. 110, 189–216 CrossRefMedline
11. Wojciechowski, J., Lai, A., Kondo, M., and Zhuang, Y. (2007) E2A and
HEB are required to block thymocyte proliferation prior to pre-TCR
expression. J. Immunol. 178, 5717–5726 CrossRefMedline
12. Miyazaki, M., Rivera, R. R., Miyazaki, K., Lin, Y. C., Agata, Y., and Murre,
C. (2011) The opposing roles of the transcription factor E2A and its antag-
onist Id3 that orchestrate and enforce the naive fate of T cells.Nat. Immu-
nol. 12, 992–1001 CrossRefMedline
13. Yang, Y., Wang, H. C., and Sun, X. H. (2008) Id1 induces apoptosis
through inhibition of RORgt expression. BMC. Immunol. 9, 20 CrossRef
Medline
14. Buenrostro, J. D., Giresi, P. G., Zaba, L. C., Chang, H. Y., and Greenleaf,
W. J. (2013) Transposition of native chromatin for fast and sensitive epige-
nomic profiling of open chromatin, DNA-binding proteins and nucleo-
some position.Nat. Methods 10, 1213–1218 CrossRefMedline
15. Hoogeveen, A. T., Rossetti, S., Stoyanova, V., Schonkeren, J., Fenaroli, A.,
Schiaffonati, L., van, U. L., and Sacchi, N. (2002) The transcriptional core-
pressor MTG16a contains a novel nucleolar targeting sequence deranged
in t(16;21)-positive myeloid malignancies. Oncogene 21, 6703–6712
CrossRefMedline
16. Amann, J. M., Nip, J., Strom, D. K., Lutterbach, B., Harada, H., Lenny, N.,
Downing, J. R., Meyers, S., and Hiebert, S. W. (2001) ETO, a target of t
(8;21) in acute leukemia, makes distinct contacts with multiple histone
deacetylases and binds mSin3A through its oligomerization domain.Mol.
Cell Biol. 21, 6470–6483 CrossRefMedline
17. Harly, C., Kenney, D., Ren, G., Lai, B., Raabe, T., Yang, Q., Cam, M. C.,
Xue, H. H., Zhao, K., and Bhandoola, A. (2019) The transcription factor
TCF-1 enforces commitment to the innate lymphoid cell lineage. Nat.
Immunol. 20, 1150–1160 CrossRefMedline
18. Chyla, B. J., Moreno-Miralles, I., Steapleton, M. A., Thompson, M. A.,
Bhaskara, S., Engel, M., and Hiebert, S.W. (2008) Deletion ofMtg16, a tar-
get of t(16;21), alters hematopoietic progenitor cell proliferation and line-
age allocation.Mol. Cell Biol. 28, 6234–6247 CrossRefMedline
19. Aronheim, A., Zandi, E., Hennemann, H., Elledge, S. J., and Karin, M.
(1997) Isolation of an AP-1 repressor by a novel method for detecting pro-
tein-protein interactions.Mol. Cell Biol. 17, 3094–3102 CrossRefMedline
20. Jin, C., Li, H., Murata, T., Sun, K., Horikoshi, M., Chiu, R., and Yokoyama,
K. K. (2002) JDP2, a repressor of AP-1, recruits a histone deacetylase 3
complex to inhibit the retinoic acid-induced differentiation of F9 cells.
Mol. Cell Biol. 22, 4815–4826 CrossRefMedline
21. Jonak, C. R., Lainez, N. M., Roybal, L. L., Williamson, A. D., and Coss, D.
(2017) c-JUN dimerization protein 2 (JDP2) is a transcriptional repressor
of follicle-stimulating hormone b (FSHb) and is required for preventing
premature reproductive senescence in female mice. J. Biol. Chem. 292,
2646–2659 CrossRefMedline
22. Muto, A., Hoshino, H., Madisen, L., Yanai, N., Obinata, M., Karasuyama,
H., Hayashi, N., Nakauchi, H., Yamamoto, M., Groudine, M., and Igarashi,
K. (1998) Identification of Bach2 as a B-cell-specific partner for small maf
proteins that negatively regulate the immunoglobulin heavy chain gene 3'
enhancer. EMBO J. 17, 5734–5743 CrossRefMedline
23. Kuwahara, M., Ise, W., Ochi, M., Suzuki, J., Kometani, K., Maruyama, S.,
Izumoto, M., Matsumoto, A., Takemori, N., Takemori, A., Shinoda, K.,
Nakayama, T., Ohara, O., Yasukawa, M., Sawasaki, T., et al. (2016) Bach2-
Batf interactions control Th2-type immune response by regulating the IL-
4 amplification loop.Nat. Commun. 7, 12596 CrossRefMedline
24. Yamashita, M., and Kuwahara, M. (2018) The critical role of Bach2 in reg-
ulating type 2 chronic airway inflammation. Int. Immunol. 30, 397–402
CrossRefMedline
25. Grigoryan, T.,Wend, P., Klaus, A., and Birchmeier,W. (2008) Deciphering
the function of canonical Wnt signals in development and disease: condi-
tional loss- and gain-of-function mutations of b-catenin in mice. Genes
Dev. 22, 2308–2341 CrossRefMedline
26. Lento, W., Congdon, K., Voermans, C., Kritzik, M., and Reya, T. (2013)
Wnt signaling in normal and malignant hematopoiesis. Cold Spring Harb.
Perspect. Biol. 5, a100801 CrossRef
27. Schwartz, C., Khan, A. R., Floudas, A., Saunders, S. P., Hams, E., Rodewald,
H. R., McKenzie, A. N. J., and Fallon, P. G. (2017) ILC2s regulate adaptive
Th2 cell functions via PD-L1 checkpoint control. J. Exp. Med. 214, 2507–
2521 CrossRefMedline
28. Neuman, K., Nornes, H. O., and Neuman, T. (1995) Helix-loop-helix tran-
scription factors regulate Id2 gene promoter activity. FEBS Lett. 374, 279–
283 CrossRef
29. Meier, N., Krpic, S., Rodriguez, P., Strouboulis, J., Monti, M., Krijgsveld, J.,
Gering, M., Patient, R., Hostert, A., and Grosveld, F. (2006) Novel binding
partners of Ldb1 are required for haematopoietic development. Develop-
ment 133, 4913–4923 CrossRefMedline
30. Tripic, T., Deng, W., Cheng, Y., Zhang, Y., Vakoc, C. R., Gregory, G. D.,
Hardison, R. C., and Blobel, G. A. (2009) SCL and associated proteins dis-
tinguish active from repressive GATA transcription factor complexes.
Blood 113, 2191–2201 CrossRefMedline
31. Hunt, A., Fischer, M., Engel, M. E., and Hiebert, S. W. (2011) Mtg16/Eto2
contributes to murine T-cell development. Mol. Cell Biol. 31, 2544–2551
CrossRefMedline
32. Ghosh, H. S., Ceribelli, M., Matos, I., Lazarovici, A., Bussemaker, H. J.,
Lasorella, A., Hiebert, S. W., Liu, K., Staudt, L. M., and Reizis, B. (2014)
ETO family protein Mtg16 regulates the balance of dendritic cell subsets
by repressing Id2. J. Exp. Med. 211, 1623–1635 CrossRefMedline
33. Engel, I., and Murre, C. (2001) The function of E- and Id proteins in lym-
phocyte development.Nat. Rev. Immunol. 1, 193–199CrossRefMedline
34. Cochrane, S. W., Zhao, Y., Welner, R. S., and Sun, X. H. (2009) Balance
between Id and E proteins regulates myeloid-versus-lymphoid lineage
decisions. Blood 113, 1016–1026 CrossRefMedline
35. Dias, S., Mansson, R., Gurbuxani, S., Sigvardsson, M., and Kee, B. L. (2008)
E2A proteins promote development of lymphoid-primedmultipotent pro-
genitors. Immunity 29, 217–227 CrossRefMedline
36. Klose, C. S., Flach,M.,Mohle, L., Rogell, L., Hoyler, T., Ebert, K., Fabiunke,
C., Pfeifer, D., Sexl, V., Fonseca-Pereira, D., Domingues, R. G., Veiga-Fer-
nandes, H., Arnold, S. J., Busslinger, M., Dunay, I. R., et al. (2014) Differen-
tiation of type 1 ILCs from a common progenitor to all helper-like innate
lymphoid cell lineages.Cell 157, 340–356 CrossRefMedline
37. Bain, G., Cravatt, C. B., Loomans, C., Alberola-Ila, J., Hedrick, S. M., and
Murre, C. (2001) Regulation of the helix-loop-helix proteins, E2A and Id3,
by the Ras-ERK MAPK cascade. Nat. Immunol. 2, 165–171 CrossRef
Medline
38. Dobin, A., Davis, C. A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S.,
Batut, P., Chaisson, M., and Gingeras, T. R. (2013) STAR: ultrafast univer-
sal RNA-seq aligner. Bioinformatics 29, 15–21 CrossRefMedline
39. Anders, S., Pyl, P. T., andHuber,W. (2015) HTSeq-a Python framework to
work with high-throughput sequencing data. Bioinformatics 31, 166–169
CrossRefMedline
40. Encode Project Consortium (2012) An integrated encyclopedia of DNA
elements in the human genome.Nature 489, 57–74 CrossRefMedline
Transcriptional regulation by E proteins in ILC2s














41. Langmead, B., and Salzberg, S. L. (2012) Fast gapped-read alignment with
Bowtie 2.Nat. Methods 9, 357–359 CrossRefMedline
42. Zhang, Y., Liu, T., Meyer, C. A., Eeckhoute, J., Johnson, D. S., Bernstein,
B. E., Nusbaum, C., Myers, R. M., Brown, M., Li, W., and Liu, X. S.
(2008) Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137
CrossRefMedline
43. Ross-Innes, C. S., Stark, R., Teschendorff, A. E., Holmes, K. A., Ali, H. R.,
Dunning, M. J., Brown, G. D., Gojis, O., Ellis, I. O., Green, A. R., Ali, S.,
Chin, S. F., Palmieri, C., Caldas, C., and Carroll, J. S. (2012) Differential oes-
trogen receptor binding is associated with clinical outcome in breast can-
cer.Nature 481, 389–393 CrossRefMedline
44. Love, M. I., Huber, W., and Anders, S. (2014) Moderated estimation of
fold change and dispersion for RNA-seq data with DESeq2. Genome Biol.
15, 550 CrossRefMedline
45. Heinz, S., Benner, C., Spann, N., Bertolino, E., Lin, Y. C., Laslo, P., Cheng, J. X.,
Murre, C., Singh, H., and Glass, C. K. (2010) Simple combinations of lineage-
determining transcription factors prime cis-regulatory elements required for
macrophage andB cell identities.Mol. Cell 38, 576–589CrossRefMedline
Transcriptional regulation by E proteins in ILC2s














Jonathan D. Wren and Xiao-Hong Sun
Vincent Peng, Constantin Georgescu, Anna Bakowska, Aneta Pankow, Liangyue Qian,
suppression of the differentiation of group 2 innate lymphoid cells
E proteins orchestrate dynamic transcriptional cascades implicated in the
doi: 10.1074/jbc.RA120.013806 originally published online August 19, 2020
2020, 295:14866-14877.J. Biol. Chem. 
  
 10.1074/jbc.RA120.013806Access the most updated version of this article at doi: 
 Alerts: 
  
 When a correction for this article is posted•  
 When this article is cited•  
 to choose from all of JBC's e-mail alertsClick here
  
 http://www.jbc.org/content/295/44/14866.full.html#ref-list-1
This article cites 45 references, 16 of which can be accessed free at
 at W
ashington U
niversity on N
ovem
ber 16, 2020
http://w
w
w
.jbc.org/
D
ow
nloaded from
 
